The Rosen Law Firm, P.A. Announces Proposed Class Action

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
115
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Tibet Pharmaceuticals, Inc. – TBET

NEWARK, N.J., Jan. 09, 2017 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. announces that the United States District Court for the District of New Jersey has approved the following announcement of a proposed class action settlement that would benefit purchasers of common stock of Tibet Pharmaceuticals, Inc. (OTCMKTS:TBET):

LEGAL NOTICE

If you bought Tibet Pharmaceuticals, Inc. stock between January 24, 2011 and April 3, 2012, you could get a payment from a class action settlement.

A settlement has been proposed in a class action lawsuit about the price of Tibet Pharmaceuticals, Inc. (“Tibet” or the “Company”) common stock.  The settlement will pay $2,075,000 to pay claims from Tibet investors who bought the Company’s common stock pursuant or traceable to Tibet’s Registration Statements and Prospectus issued in connection with Tibet’s Initial Public Offering of Stock (“IPO”) on or about January 24, 2011 or 2) purchased or otherwise acquired Tibet common stock from January 24, 2011 to April 3, 2012, both dates inclusive.  If you qualify, you may send in a claim form to get benefits, or you can exclude yourself to the settlement, or object to it.   The United States District Court for the District of New Jersey authorized this notice.  Before any money is paid, the Court will have a hearing to decide whether to approve the settlement.

If You submitted a valid and timely proof of claim form in the Settlement with Anderson & Strudwick, You are automatically eligible for recovery in this case without needing to submit another proof of claim and release form.  To find out if you previously submitted a valid proof of claim form in the Anderson & Strudwick Settlement, Contact the Claims Administrator at (866) 274-4004.

WHO’S INCLUDED?

You are a class member and could get benefits if you bought shares of Tibet stock from January 24, 2011 through April 3, 2012.  You are a Class Member only if you bought shares of Tibet stock individually not simply through a mutual fund.  Tibet’s officers and directors, as well as immediate family members of directors of Tibet are not Class Members.  Contact your broker to see if you had shares of Tibet stock.  If you’re not sure you are included you can get more information, including a detailed notice, at www.strategicclaims.net or by calling toll free 866-274-4004.

WHAT’S THIS ABOUT?

The lawsuit claims that Tibet solicited investors for its IPO with a registration statement and prospectus that contained false financial information about Tibet, because, among other reasons, Tibet was insolvent at the time of the IPO, the lawsuit alleges that Tibet’s auditor Acquavella, Chiarelli, Shuster & Berkower, LLP (“ACSB”) failed to conduct a proper audit of Tibet’s financial statements contained in the Registration Statement.  ACSB denies that it did anything wrong.  The Court did not decide which side was right.  But both ACSB and Plaintiffs agreed to the settlement to resolve the case as to ACSB and get benefits to investors.  Plaintiffs and ACSB, disagree on how much money could have been won if the investors had won at a trial.

WHAT DOES THE SETTLEMENT PROVIDE?

ACSB agreed to create a fund of $2.075 million to be divided among all Class Members who send in valid claim forms.  A Stipulation of Settlement, available at www.strategicclaims.net , describes all of the details about the proposed settlement.

Your share of the fund will depend on the number of valid claim forms that Class Members send in, how many shares of Tibet stock you bought, and when you bought and sold them.  Generally, if you bought more shares and have more Recognized Losses (as explained in the detailed notice), you will get more money.  If you bought fewer shares and have fewer Recognized Losses, you will get less.  All of the $2.075 million will be paid out.

If every eligible Class Member sends in a valid claim form the average payment will be $0.14 per share for each share of Tibet stock outstanding as of April 3, 2012, before deduction of attorneys’ fees, and expenses and approximately $0.08 per share after deduction of attorneys’ fees and expenses.  The number of claimants who send in claims varies widely from case to case.  If less than 100% of the Class sends in a claim form, you could get more money.

HOW DO YOU ASK FOR A PAYMENT?

A detailed notice and claim form package contains everything you need.  Just call 866-274-4004 or visit www.strategicclaims.net to get one.  To qualify for a payment, you must send in a claim form unless you submitted one in the Anderson & Strudwick settlement.  Claim forms must be submitted to the Claims Administrator by February 27, 2017.

WHAT ARE YOUR OTHER OPTIONS?

If you don’t want to be legally bound by the settlement, you must exclude yourself by May 16, 2017 , or you won’t be able to sue or continue to sue ACSB about the legal claims in this case.  If you exclude yourself, you can’t get money from this settlement. If you stay in the settlement, you may object to it by May 23, 2017 .  The detailed notice explains how to exclude yourself or object.

The Court will hold a hearing in this case ( Dartell v. Tibet Pharmaceuticals, Inc. et al. , Case No. 14-cv-3620) on June 6, 2017 to consider whether the approve the settlement and a request by the lawyers representing all Class Members (The Rosen Law Firm, PA, of New York, NY) for attorneys’ fees of not more than one third of the Settlement Amount or $691,667, reimbursement of total litigation expenses of no more than $150,000, and an award to the Class Plaintiffs not to exceed $30,000 (or $5,000 for each of the six Class Plaintiffs).  Collectively, the attorneys’ fees and expenses are estimated to average $0.058 per share of Tibet Stock.  You may ask to appear at the hearing but you don’t have to.  For more information, call toll free 866-274-4004, visit the website at www.strategicclaims.net ., or write to Dartell v. Tibet Pharmaceuticals, Inc. et al , c/o Strategic Claims Services, P.O. Box 230, 600 N. Jackson St., Ste. 3, Media, PA 19063.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Local Bounti Expands: Acquires CEA Facilities

Updated Category News Views 96

Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...

Continue Reading
Investors, Portillo's Fraud Claims Demand Your Attention

Updated Category News Views 91

Portillo's Investors Caught in a Tough Spot Ah, Portillo's. You thought those hot dogs were the only spicy thing you're biting into? Try these allegations on for size. Investors are biting back with a securities fraud lawsuit, and the details are saltier than a bucket of fries. The folks who held PTLO shares between September 19, 2023, and May 4, 2026, are in the...

Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 137

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
Lear Gears Up for Goldman Sachs Event Spotlight

Updated Category News Views 132

Lear Prepares for the Big Stage in London Autumn leaves and industry insights are falling in full swing as Lear Corporation gets its ducks in a row for the upcoming Goldman Sachs 18th Annual Industrials & Autos Week. Kicking off on December 3, 2026, this gathering in London isn't just another checkbox on their corporate calendar—it's a prime moment in the spotlight....

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 149

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
Norris Lake's New Kayak Fleet Propels Tourism Efforts

Updated Category News Views 207

Norris Lake Doubles Down on Water Adventures The winds of change are paddling through Norris Dam State Park as they've launched a new fleet of shiny kayaks, hoping to lure more adventure seekers into the heart of Tennessee. These ain't just boats; they're part of a bigger play by local tourism honchos hungry to pump some adrenaline—and dollars—back into the area. A...

Continue Reading
Sabre Unveils AI Travel Tech: A Bold New Frontier

Updated Category News Views 110

Sabre's Game-Changing AI Travel Integration I'm no stranger to bold moves in the travel industry, but what Sabre's rolling out tomorrow might just be the biggest leap we've seen in a while. They're unleashing what's called the first global travel plug-in within Grok Bot, marking a significant shake-up in the travel tech sphere. Too many tech upgrades in this business...

Continue Reading
Ave7® Pioneers AI-Driven Marketplace Evolution

Updated Category News Views 99

AI Reshapes the Agency Paradigm Nobody saw this coming a decade ago, but here we are—AI's taking the wheel, but with humans still riding shotgun. The agency world, particularly the one dealing with e-commerce giants like Amazon, Walmart, and Target, has flipped on its head. Ave7® steps up as the frontrunner, adapting faster than a broker's reflex after a market bell....

Continue Reading
Grupo Supervielle's Q3 2026: Back to Growth Path

Updated Category News Views 66

Mounting Momentum in Loans and Asset Quality Grupo Supervielle, the Argentine financial player, has been tinkering with its gears to navigate the bumpy roads of 2026. In the third quarter, the company reports a gentle uptick in net loans—up 1.3% sequentially. This was particularly felt in September, with loans increasing 3.7%. Holding Their Own Against the Industry...

Continue Reading
Vertiv's 800 VDC Push Gives AI Builders More Choices

Updated Category News Views 48

Electricity is becoming the awkward roommate inside every serious AI buildout, and Vertiv is trying to move it out of the rack before it eats the whole house. The company has expanded its 800 VDC offering beyond the PowerDirect 5000 rack product introduced in May 2026, laying out systems for the rack, the AI compute pod, and the full data hall. For investors following...

Continue Reading

Top 5 Most Recently Viewed Articles

Future Tech Boosts Leadership with Mike Watkinson's Appointment

Updated Category News Views 156

Future Tech Welcomes New CRO to Boost Revenue Strategy Future Tech Enterprise, Inc., a reputable provider of technology solutions, has recently appointed Mike Watkinson as its new Chief Revenue Officer (CRO). In this role, he will be responsible for driving global revenue growth and improving sales strategies for the company. This appointment follows a recent expansion of...

Continue Reading
Supporting Careers of Migraine Sufferers: AbbVie Contest Open

Updated Category News Views 250

AbbVie Launches the Second Annual Career Catalyst Award for Migraine Sufferers AbbVie has opened the entries for the second annual AbbVie Migraine Career Catalyst Award™ contest, offering significant financial assistance to help winners achieve their career aspirations. This initiative is designed to empower individuals living with migraine in their professional...

Continue Reading
Shane Neil Joins Axis Insurance as Senior VP for Eastern Canada

Updated Category News Views 116

So, Axis Insurance shook things up back when they named Shane Neil as their Senior Vice President of Corporate Development for Eastern Canada. This guy's got over 20 years in the insurance game, having kicked off his career at Chubb and moving through some heavyweight roles since then. Traders were eyeing this appointment, knowing that big names can mean bigger moves in...

Continue Reading
Water Ways Technologies Reports Q2 2024 Financial Insights

Updated Category News Views 74

Water Ways Technologies Inc. Reports Q2 2024 Financial Results Water Ways Technologies Inc. (TSXV: WWT) has released its financial results for the second quarter of 2024. As a prominent provider of agricultural technology based in Israel, the company focuses on improving water irrigation solutions and is dedicated to fostering innovation in the agriculture industry....

Continue Reading
Celebrating Technological Excellence: Mats Karlsson's Acclaimed Achievement

Updated Category News Views 116

Icomera Honors CTO Mats Karlsson with the Polhem Prize 2025 Icomera is thrilled to announce that its Chief Technology Officer, Mats Karlsson, has been awarded the Polhem Prize 2025. This esteemed recognition is one of Sweden's highest honors for outstanding contributions to technological innovation, presented by the Swedish Association of Graduate Engineers. The...

Continue Reading